We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.74B
AUM Growth
+$109M
Cap. Flow
-$39.8M
Cap. Flow %
-1.07%
Top 10 Hldgs %
14.14%
Holding
1,395
New
97
Increased
557
Reduced
530
Closed
105

Sector Composition

Rank Sector Weight
1 Healthcare 13.61%
2 Financials 11.8%
3 Technology 10.96%
4 Industrials 9.65%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDIV icon
751
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$429M
$654K 0.02%
34,118
-1,230
-3% -$23.7K
FTSL icon
752
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$653K 0.02%
13,550
-683
-5% -$33.1K
TRI icon
753
Thomson Reuters
TRI
$42.8B
$651K 0.02%
12,220
+446
+4% +$23.8K
DAR icon
754
Darling Ingredients
DAR
$9.64B
$649K 0.02%
37,050
+2,065
+6% +$35K
FFC
755
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$777M
$648K 0.02%
30,290
+245
+0.8% +$5.21K
GLO
756
Clough Global Opportunities Fund
GLO
$250M
$648K 0.02%
58,007
-1,279
-2% -$14.2K
EMF
757
Templeton Emerging Markets Fund
EMF
$317M
$646K 0.02%
+39,200
New +$630K
NMFC icon
758
New Mountain Finance
NMFC
$651M
$645K 0.02%
45,294
+33,041
+270% +$469K
STEW
759
SRH Total Return Fund
STEW
$1.79B
$643K 0.02%
63,013
+1,253
+2% +$12.5K
CEN
760
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$643K 0.02%
6,092
+1,733
+40% +$185K
ALXN
761
DELISTED
Alexion Pharmaceuticals
ALXN
$640K 0.02%
4,561
+383
+9% +$52K
DWAS icon
762
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$429M
$639K 0.02%
+13,481
New +$592K
EA icon
763
Electronic Arts
EA
$53B
$639K 0.02%
5,416
+1,223
+29% +$142K
FBT icon
764
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$639K 0.02%
5,157
+332
+7% +$39.3K
JACK icon
765
Jack in the Box
JACK
$312M
$639K 0.02%
6,269
-1,179
-16% -$113K
SRCL
766
DELISTED
Stericycle Inc
SRCL
$638K 0.02%
8,912
-171
-2% -$12.6K
SPGI icon
767
S&P Global
SPGI
$121B
$637K 0.02%
4,075
+75
+2% +$11.4K
PCY icon
768
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$635K 0.02%
21,344
+1,641
+8% +$48.6K
PWV icon
769
Invesco Large Cap Value ETF
PWV
$1.68B
$634K 0.02%
16,977
-373
-2% -$13.6K
EVV
770
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$633K 0.02%
45,146
-1,077
-2% -$15.1K
FDL icon
771
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
$633K 0.02%
21,815
-434
-2% -$12.3K
UA icon
772
Under Armour Class C
UA
$2.77B
$628K 0.02%
41,769
+8,906
+27% +$150K
ALK icon
773
Alaska Air
ALK
$5.29B
$624K 0.02%
8,182
-500
-6% -$40.9K
BANX
774
ArrowMark Financial
BANX
$198M
$618K 0.02%
29,926
-1,053
-3% -$21.4K
USA icon
775
Liberty All-Star Equity Fund
USA
$1.79B
$617K 0.02%
102,400
-8,073
-7% -$46.4K

Similar funds

Oppenheimer & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Oppenheimer & Co held 1,395 positions worth $3.74B, up 3% from $3.63B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2017 filing shows 97 new, 557 increased, 530 reduced and 105 closed positions. Its largest new stake was Jacobs Solutions: 99,458 shares worth $4.79M. The largest sale was Du Pont De Nemours E I, an estimated $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q3 2017 buy was Jacobs Solutions: 99,458 shares worth $4.79M.
  • Oppenheimer & Co added most to DuPont de Nemours in Q3 2017, an estimated $13.6M increase.
  • Oppenheimer & Co's biggest Q3 2017 reduction was Amgen, cutting an estimated $5.53M.
  • Oppenheimer & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $13.5M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.74B portfolio in Q3 2017.
  • Oppenheimer & Co opened 97 new positions and closed 105 in Q3 2017.
  • Oppenheimer & Co's portfolio value rose 3% quarter-over-quarter to $3.74B.

Based on Oppenheimer & Co's 13F filing for Q3 2017, filed 9 Nov 2017.